Acute Subjective Effects of Psychedelics within and Beyond WEIRD Contexts

References

• Andritzky, W. 1989. Sociopsychotherapeutic functions of ayahuasca healing in amazonia. Journal of Psychoactive Drugs 21 (1):77–89. doi:10.1080/02791072.1989.10472145.
   PubMed Web of Science ®Google Scholar
• Argento, E., R. Capler, G. Thomas, P. Lucas, and K. W. Tupper. 2019. Exploring ayahuasca‐assisted therapy for addiction: A qualitative analysis of preliminary findings among an indigenous community in Canada. Drug and Alcohol Review 38 (7):781–89. doi:10.1111/dar.12985.
   PubMed Web of Science ®Google Scholar
• Barone, W., M. Mitsunaga-Whitten, L. O. Blaustein, P. Perl, M. Swank, and T. C. Swift. 2022. Facing death, returning to life: A qualitative analysis of MDMA-assisted therapy for anxiety associated with life-threatening illness. Frontiers in Psychiatry 13:944849. doi:10.3389/fpsyt.2022.944849.
   PubMed Web of Science ®Google Scholar
• Barrett, F. S., M. P. Bradstreet, J.-M. S. Leoutsakos, M. W. Johnson, and R. R. Griffiths. 2016. The challenging experience questionnaire: Characterization of challenging experiences with psilocybin mushrooms. Journal of Psychopharmacology (Oxford, England) 30 (12):1279–95. doi:10.1177/0269881116678781.
   PubMed Web of Science ®Google Scholar
• Barrett, F. S., M. W. Johnson, and R. R. Griffiths. 2015. Validation of the revised mystical experience questionnaire in experimental sessions with psilocybin. Journal of Psychopharmacology (Oxford, England) 29 (11):1182–90. doi:10.1177/0269881115609019.
   PubMed Web of Science ®Google Scholar
• Belser, A. B., G. Agin-Liebes, T. C. Swift, S. Terrana, N. Devenot, H. L. Friedman, J. Guss, A. Bossis, and S. Ross. 2017. patient experiences of psilocybin-assisted psychotherapy: an interpretative phenomenological analysis. Journal of Humanistic Psychology 57 (4):354–88. doi:10.1177/0022167817706884.
   Web of Science ®Google Scholar
• Béteille, A. 1998. The idea of indigenous people. Current Anthropology 39 (2):187–92. doi:10.1086/204717.
   Web of Science ®Google Scholar
• Carod-Artal, F. J., and C. B. Vázquez Cabrera. 2007. Ritual use of anadenanthera seeds among South America natives. Neurologia (Barcelona, Spain) 22 (6):410–15.
   PubMed Web of Science ®Google Scholar
• Davis, A. K., J. M. Clifton, E. G. Weaver, E. S. Hurwitz, M. W. Johnson, and R. R. Griffiths. 2020. Survey of entity encounter experiences occasioned by inhaled N,N-dimethyltryptamine: phenomenology, interpretation, and enduring effects. Journal of Psychopharmacology (Oxford, England) 34 (9):1008–20. doi:10.1177/0269881120916143.
   PubMed Web of Science ®Google Scholar
• de Mori, B. B. 2011. Tracing hallucinations – contributing to a critical ethnohistory of ayahuasca usage in the Peruvian amazon. In The Internationalization of Ayahuasca, ed. B. C. Labate and H. Jungaberle, 23–47. Zürich: LIT-Verlag.
   Google Scholar
• Dittrich, A. 1998. The standardized psychometric assessment of altered states of consciousness (ASCs) in humans. Pharmacopsychiatry 31 (Suppl):80–84. doi:10.1055/s-2007-979351.
   PubMedGoogle Scholar
• Dole, G. E. 1974. The marriages of pacho: A woman’s life among the amahuaca 3–35. Free Press, https://ehrafworldcultures.yale.edu/cultures/se06/documents/005.
   Google Scholar
• El-Seedi, H. R., P. A. G. M. D. Smet, O. Beck, G. Possnert, and J. G. Bruhn. 2005. Prehistoric peyote use: Alkaloid analysis and radiocarbon dating of archaeological specimens of Lophophora from texas. Journal of Ethnopharmacology 101 (1):238–42. doi:10.1016/j.jep.2005.04.022.
   PubMed Web of Science ®Google Scholar
• Gasser, P., K. Kirchner, and T. Passie. 2015. LSD-assisted psychotherapy for anxiety associated with a life-threatening disease: A qualitative study of acute and sustained subjective effects. Journal of Psychopharmacology 29 (1):57–68. doi:10.1177/0269881114555249.
   PubMed Web of Science ®Google Scholar
• Gray, A. 1996. The Arakmbut of Amazonian Peru. Providence: Berghahn Books.
   Google Scholar
• Griffiths, R. R., E. S. Hurwitz, A. K. Davis, M. W. Johnson, R. Jesse, and R. Frey. 2019. Survey of subjective “god encounter experiences”: Comparisons among naturally occurring experiences and those occasioned by the classic psychedelics psilocybin, LSD, ayahuasca, or DMT. PLOS ONE 14 (4):e0214377. doi:10.1371/journal.pone.0214377.
   PubMed Web of Science ®Google Scholar
• Griffiths, R. R., W. A. Richards, U. McCann, and R. Jesse. 2006. Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance. Psychopharmacology 187 (3):268–83. discussion 284-292. doi:10.1007/s00213-006-0457-5.
   PubMed Web of Science ®Google Scholar
• Harman, W. W., R. H. Mckim, R. E. Mogar, J. Fadiman, and M. J. Stolaroff. 1966. Psychedelic agents in creative problem-solving: A pilot study. Psychological Reports 19 (1):211–27. doi:10.2466/pr0.1966.19.1.211.
   PubMed Web of Science ®Google Scholar
• Harner, M., Ed. 1979. Hallucinogens and shamanism. London: Oxford University Press.
   Google Scholar
• Hartogsohn, I. 2020. American trip: Set, setting, and the psychedelic experience in the twentieth century. The MIT Press.
   Google Scholar
• Harvey, P., and P. Gow, Eds. 1994. Sex and violence: issues in representation and experience. London: Routledge.
   Google Scholar
• Henrich, J., S. J. Heine, and A. Norenzayan. 2010. The weirdest people in the world? Behavioral and Brain Sciences 33 (2–3):61–83. doi:10.1017/S0140525X0999152X.
   PubMed Web of Science ®Google Scholar
• Jay, M. 2019. Mescaline: A global history of the first psychedelic. First Edition. Yale University Press. doi:10.12987/9780300245080.
   Google Scholar
• Katz, S. T. 1978. Language, epistemology, and mysticism. In Mysticism and philosophical analysis, ed. S. T. Katz, 22–74. New York: Oxford University Press.
   Google Scholar
• Kensinger, K. M., and M. J. Harner. 1973. Banisteriopsis usage among the Peruvian Cashinahua in Hallucinogens and Shamanism, 9–14. New York: Oxford University Press.
   Google Scholar
• Kopenawa, D., and B. Albert. 2013. The falling sky: Words of a Yanomami shaman. Belknap Press. doi:10.2307/j.ctt6wppk9.
   Google Scholar
• Kuper, A. 2003. The return of the native. Current Anthropology 44 (3):389–402. doi:10.1086/368120.
   Web of Science ®Google Scholar
• Lafrance, A., A. Loizaga-Velder, J. Fletcher, M. Renelli, N. Files, and K. W. Tupper. 2017. Nourishing the spirit: Exploratory research on ayahuasca experiences along the continuum of recovery from eating disorders. Journal of Psychoactive Drugs 49 (5):427–35. doi:10.1080/02791072.2017.1361559.
   PubMed Web of Science ®Google Scholar
• Lawrence, D. W., R. Carhart-Harris, R. Griffiths, and C. Timmermann. 2022. Phenomenology and content of the inhaled N, N-dimethyltryptamine (N, N-DMT) experience. Scientific Reports 12 (1):8562.
   PubMed Web of Science ®Google Scholar
• Liechti, M. E., P. C. Dolder, and Y. Schmid. 2017. Alterations of consciousness and mystical-type experiences after acute LSD in humans. Psychopharmacology 234 (9–10):1499–510. doi:10.1007/s00213-016-4453-0.
   PubMed Web of Science ®Google Scholar
• Malone, T. C., S. E. Mennenga, J. Guss, S. K. Podrebarac, L. T. Owens, A. P. Bossis, A. B. Belser, G. Agin-Liebes, M. P. Bogenschutz, and S. Ross. 2018. Individual experiences in four cancer patients following psilocybin-assisted psychotherapy. Frontiers in Pharmacology 9:256. doi:10.3389/fphar.2018.00256.
   PubMed Web of Science ®Google Scholar
• Michael, P., D. Luke, and O. Robinson. 2021. An encounter with the other: A thematic and content analysis of dmt experiences from a naturalistic field study. Frontiers in Psychology 12:720717. doi:10.3389/fpsyg.2021.720717.
   PubMed Web of Science ®Google Scholar
• Nautiyal, K. M., and D. B. Yaden. 2023. Does the trip matter? Investigating the role of the subjective effects of psychedelics in persisting therapeutic effects. Neuropsychopharmacology 48 (1):215–16. doi:10.1038/s41386-022-01424-z.
   PubMed Web of Science ®Google Scholar
• Nichols, D. E., C. D. Nichols, and P. S. Hendricks. 2023. Proposed consensus statement on defining psychedelic drugs. Psychedelic Medicine 1 (1):12–13. doi:10.1089/psymed.2022.0008.
   Google Scholar
• Nichols, D. E., and H. Walter. 2021. The history of psychedelics in psychiatry. Pharmacopsychiatry 54 (4):151–66. doi:10.1055/a-1310-3990.
   PubMedGoogle Scholar
• Nielson, E. M., D. G. May, A. A. Forcehimes, and M. P. Bogenschutz. 2018. The psychedelic debriefing in alcohol dependence treatment: Illustrating key change phenomena through qualitative content analysis of clinical sessions. Frontiers in Pharmacology 9:132. doi:10.3389/fphar.2018.00132.
   PubMed Web of Science ®Google Scholar
• Noorani, T., A. Garcia-Romeu, T. C. Swift, R. R. Griffiths, and M. W. Johnson. 2018. Psychedelic therapy for smoking cessation: Qualitative analysis of participant accounts. Journal of Psychopharmacology 32 (7):756–69. doi:10.1177/0269881118780612.
   PubMed Web of Science ®Google Scholar
• Pahnke, W. N., A. A. Kurland, L. E. Goodman, and W. A. Richards. 1969. LSD-assisted psychotherapy with terminal cancer patients. Current Psychiatric Therapies 9:144–52.
   PubMedGoogle Scholar
• Palamar, J. J., and P. Acosta. 2020. A qualitative descriptive analysis of effects of psychedelic phenethylamines and tryptamines. Human Psychopharmacology: Clinical & Experimental 35 (1). doi:10.1002/hup.2719.
   PubMed Web of Science ®Google Scholar
• Passie, T., J. Guss, and R. Krähenmann. 2022. Lower-dose psycholytic therapy – a neglected approach. Frontiers in Psychiatry 13:1020505. doi:10.3389/fpsyt.2022.1020505.
   PubMed Web of Science ®Google Scholar
• Reichel-Dolmatoff, G. 1971. Amazonian cosmos: The sexual and religious symbolism of the Tukano Indians. 4 Aufl. Chicago: Univ. of Chicago Pr
   Google Scholar
• Reichel-Dolmatoff, G. 1978. Beyond the Milky Way: Hallucinatory imagery of the Tukano Indians. Los Angeles: UCLA Latin American Center Publications. http://archive.org/details/beyondmilkywayha0000reic.
   Google Scholar
• Reichel-Dolmatoff, G. 1987. Shamanism and art of the eastern Tukanoan Indians: Colombian northwest Amazon. New York: E.J. Brill.
   Google Scholar
• Rodd, R. 2006. Piaroa sorcery and the navigation of negative affect: To be aware, to turn away. Anthropology of Consciousness 17 (1):35–64. doi:10.1525/ac.2006.17.1.35.
   Google Scholar
• Schaefer, S. B. 2006. Shamans, peyote, and coca sacraments: A path that maintains indigenous traditions and identity in a time of globalization. Cultura Y Droga (13):145–172.
   Google Scholar
• Shanon, B. 2003. The antipodes of the mind: Charting the phenomenology of the ayahuasca experience. 1st ed. Oxford: Oxford University Press.
   Google Scholar
• Singh, M. (2023, February 20). It’s time to rethink the idea of the “Indigenous.” The New Yorker. https://www.newyorker.com/magazine/2023/02/27/its-time-to-rethink-the-idea-of-the-indigenous
   Google Scholar
• Slotkin, J. S. 1956. The peyote religion. 1st ed. Glengoe: The Free Press.
   Google Scholar
• Studerus, E., A. Gamma, F. X. Vollenweider, and V. Bell. 2010. Psychometric evaluation of the altered states of consciousness rating scale (OAV). PLOS ONE 5 (8):e12412. doi:10.1371/journal.pone.0012412.
   PubMed Web of Science ®Google Scholar
• Swift, T. C., A. B. Belser, G. Agin-Liebes, N. Devenot, S. Terrana, H. L. Friedman, J. Guss, A. P. Bossis, and S. Ross. 2017. Cancer at the dinner table: Experiences of psilocybin-assisted psychotherapy for the treatment of cancer-related distress. Journal of Humanistic Psychology 57 (5):488–519. doi:10.1177/0022167817715966.
   Web of Science ®Google Scholar
• Taves, A., E. D. Ihm, M. G. Wolf, M. Barlev, M. Kinsella, and M. Vyas. 2023. The inventory of nonordinary experiences (INOE): Evidence of validity in the United States and India. Preprint] PsyArxiv. doi:10.31234/osf.io/r6bw9.
   Google Scholar
• Wallace, A. F. C. 1959. Cultural determinants of response to hallucinatory experience. AMA Archives of General Psychiatry 1 (1):58–69. doi:10.1001/archpsyc.1959.03590010074009.
   PubMed Web of Science ®Google Scholar
• Watts, R., C. Day, J. Krzanowski, D. Nutt, and R. Carhart-Harris. 2017. patients’ accounts of increased “connectedness” and “acceptance” after psilocybin for treatment-resistant depression. Journal of Humanistic Psychology 57 (5):520–64. doi:10.1177/0022167817709585.
   Web of Science ®Google Scholar
• Yaden, D. B., and R. R. Griffiths. 2020. The subjective effects of psychedelics are necessary for their enduring therapeutic effects. ACS Pharmacology and Translational Science 4 (2):568–72. doi:10.1021/acsptsci.0c00194.
   PubMedGoogle Scholar
• Yaden, D. B., and A. Newberg. 2022. The varieties of spiritual experience: 21st century research and perspectives. Oxford University Press. doi:10.1093/oso/9780190665678.001.0001.
   Google Scholar